1. Yang H. Benefits-risks of Pfizer-BioNTech covid-19 vaccine for ages 5 to 11 years. US Food and Drug Administration meeting presentation. 26 Oct 2021. https://www.fda.gov/media/153507/download
2. Covid-19: Regulators warn that rare Guillain-Barré cases may link to J&J and AstraZeneca vaccines
3. Ball L. FDA review of effectiveness and safety of Pfizer-BioNTech covid-19 vaccine in children 5 through 11 years of age: emergency use authorization amendment. 26 Oct 2021. https://www.fda.gov/media/153510/download
4. McGinley L, Shepherd K. FDA advisers back Pfizer-BioNTech coronavirus vaccine for children 5 to 11, saying benefits outweigh risks. Washington Post 2021 Oct 26. https://www.washingtonpost.com/health/2021/10/26/covid-vaccine-children-pfizer/
5. Lopes L, Hamel L, Sparks G, et al. KFF COvid-19 vaccine monitor: vaccination trends among children and covid-19 in schools. Kaiser Family Foundation. 30 Sep 2021. https://www.kff.org/coronavirus-covid-19/poll-finding/kff-covid-19-vaccine-monitor-trends-among-children-school/